ClinicalTrials.Veeva

Menu

Using Deep Learning and Radiomics to Diagnose Benign and Malignant Breast Lesions Based on Ultrasound

M

Ma Zhe

Status

Completed

Conditions

Breast Diseases

Study type

Observational

Funder types

Other

Identifiers

NCT06069921
YXLL-KY-2023(045)

Details and patient eligibility

About

This retrospective study aimed to create a prediction model using deep learning and radiomics features extracted from intratumoral and peritumoral regions of breast lesions in ultrasound images, to diagnose benign and malignant breast lesions with BI-RADS 4 classification.

Materials and methods: Patients who visited in The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital were collected. Their general clinical features, information on preoperative ultrasound diagnosis, and postoperative pathologic data were reviewed.

Enrollment

400 patients

Sex

Female

Ages

15 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • female patients with US-visible solid breast masses who underwent biopsy and/or surgical resection, and were classified as having BI-RADS 4 lesions in medical US reports.

Exclusion criteria

  • preoperative endocrine therapy, chemotherapy, or radiotherapy, preoperative invasive breast operation, insufficient image quality, and no pathological results.

Trial design

400 participants in 2 patient groups

maligant
Description:
female patients with US-visible solid maligant breast masses who underwent biopsy and/or surgical resection.
benign
Description:
female patients with US-visible solid benign breast masses who underwent biopsy and/or surgical resection.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems